Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus

Roux-en-Y gastric bypass and sleeve gastrectomy induce substantial and persistent changes in microbial communities and metabolic pathways

(2022) Jerry T. Dang et al.   Gut Microbes

FGF19 protects skeletal muscle against obesity‐induced muscle atrophy, metabolic derangement and abnormal irisin levels via the AMPK/SIRT‐1/PGC‐α pathway

(2021) Ai Guo et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Roux-En-Y Gastric Bypass Versus Sleeve Gastrectomy Plus Procedures for Treatment of Morbid Obesity: Systematic Review and Meta-Analysis

(2021) Gang Chen et al.   OBESITY SURGERY

EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus

(2021) Anna Obermayer et al.   Biomolecules

Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic Syndrome

(2020) Natascha Roehlen et al.   OBESITY SURGERY

The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids

(2020) Michael A. Glaysher et al.   CLINICAL NUTRITION

A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease

(2020) Hassan Ghoz et al.   Clinical and Translational Gastroenterology

Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity

(2020) Tatsuo Kawai et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans

(2019) F. Samuel van Nierop et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation

(2019) B. Betzel et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Is Early Reimplantation of the Duodenal–Jejunal Bypass Liner Viable?

(2019) Eleni Leventi et al.   OBESITY SURGERY

Metabolic improvement in obese patients after duodenal–jejunal exclusion is associated with intestinal microbiota composition changes

(2019) C. de Jonge et al.   INTERNATIONAL JOURNAL OF OBESITY

Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study

(2018) Katharina Laubner et al.   DIABETES OBESITY & METABOLISM

Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL)

(2018) Nina Riedel et al.   OBESITY SURGERY

Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review

(2018) Bark Betzel et al.   OBESITY SURGERY

Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients

(2018) Liat Deutsch et al.   Surgery for Obesity and Related Diseases

Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner

(2017) Bark Betzel et al.   GASTROINTESTINAL ENDOSCOPY

The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes

(2016) Ulrich Rohde et al.   DIABETES OBESITY & METABOLISM

Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders

(2016) B. Stratmann et al.   HORMONE AND METABOLIC RESEARCH

Endocrine effects of duodenal–jejunal exclusion in obese patients with type 2 diabetes mellitus

(2016) Petra Kaválková et al.   JOURNAL OF ENDOCRINOLOGY

Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism

(2016) Nuria Vilarrasa et al.   OBESITY SURGERY

Hepatic abscess as a complication of duodenal-jejunal bypass sleeve system and review of the literature

(2016) Umberto Maggi et al.   Surgery for Obesity and Related Diseases

Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study

(2016) Bark Betzel et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity

(2015) A S Kelly et al.   INTERNATIONAL JOURNAL OF OBESITY

Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review

(2015) G Abdeen et al.   OBESITY SURGERY

Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients

(2015) Eduardo Guimarães Hourneaux de Moura et al.   OBESITY SURGERY

Relief of diabetes by duodenal-jejunal bypass sleeve implantation in the high-fat diet and streptozotocin-induced diabetic rat model is associated with an increase in GLP-1 levels and the number of GLP-1-positive cells

(2015) JINQUAN SHUANG et al.   Experimental and Therapeutic Medicine

Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes

(2015) Kirsten Lindegaard et al.   Diabetology & Metabolic Syndrome

The Effect of the Endoscopic Duodenal-Jejunal Bypass Liner on Obesity and Type 2 Diabetes Mellitus, a Multicenter Randomized Controlled Trial

(2014) Parviez Koehestanie et al.   ANNALS OF SURGERY

Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action

(2013) Jonathan E. Campbell et al.   Cell Metabolism

Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes

(2013) Charlotte de Jonge et al.   OBESITY SURGERY

Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes

(2013) Charlotte de Jonge et al.   OBESITY SURGERY

The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes

(2013) Shaneel R.H. Patel et al.   Surgery for Obesity and Related Diseases

The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control

(2012) Dimitri J. Pournaras et al.   ENDOCRINOLOGY

The importance of the gut microbiota after bariatric surgery

(2012) Judith Aron-Wisnewsky et al.   Nature Reviews Gastroenterology & Hepatology

Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal–Jejunal Bypass Liner

(2011) Eduardo G.H. de Moura et al.   Diabetes Technology & Therapeutics

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk

(2011) J. V. Li et al.   GUT

A Multicenter, Randomized Efficacy Study of the EndoBarrier Gastrointestinal Liner for Presurgical Weight Loss Prior to Bariatric Surgery

(2010) Ruben Schouten et al.   ANNALS OF SURGERY

Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates

(2010) Keith S. Gersin et al.   GASTROINTESTINAL ENDOSCOPY

The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

(2008) W. Kim et al.   PHARMACOLOGICAL REVIEWS

Evolution of Mammals and Their Gut Microbes

(2008) R. E. Ley et al.   SCIENCE

First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve

(2008) Leonardo Rodriguez-Grunert et al.   Surgery for Obesity and Related Diseases

Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein

(2008) Varun Agrawal et al.   Surgery for Obesity and Related Diseases

Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery

(2008) M. Tarnoff et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES